Gregory Berger

Greg Berger provides due diligence and advisory services to private equity firms investing in the healthcare sector.

He applies his technical expertise and background in traditional Medicare, Medicare Advantage, and Part D policy analysis to assist financial services firms in understanding complex healthcare payment and regulatory issues.

Prior to joining Avalere, Greg served as the vice president of Medicare policy at America’s Health Insurance Plans (AHIP). At AHIP, Greg developed strong working relationships with federal government officials to advocate on behalf of the Medicare Advantage industry and led strategic discussions among member health plans to develop key advocacy positions on a wide range of payment-related issues. Prior to his time at AHIP, Greg was a consultant at Dobson DaVanzo & Associates, where he conducted original research and managed projects for clients in both the public and private sectors related to Medicare and Medicaid payment policy.

Greg has an MPP from Georgetown University and a BA from the University of Pennsylvania.

Authored Content

The Kidney Care Choices (KCC) model, a new alternative payment model launched by the Center for Medicare and Medicaid Innovation (CMMI), is scheduled to begin on January 1, 2022. This model will provide population-based payments for beneficiaries with both advanced-stage chronic kidney disease (CKD) and end-stage renal disease (ESRD) to improve patient health outcomes and lower Medicare fee-for-service (FFS) spending.